Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolomic Profiling Based on Nuclear Magnetic Resonance in Fibromyalgia Patients

NCT06725199 is registered in ClinicalTrials.gov with hatice kübra aşık as lead sponsor.

NCT NCT06725199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06725199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolomic Profiling Based on Nuclear Magnetic Resonance in Fibromyalgia Patients
Lead sponsor
hatice kübra aşık
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 1, 2024
Completion date
February 28, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia syndrome, patients with clinical complaints of fibromyalgia among the patients applying to the outpatient clinic